What were the key takeaways from Weave Communications's earnings call?

What is Weave Communications's latest dividend and current dividend yield?

What guidance did Weave Communications's management provide for the next earnings period?

What is Weave Communications's gross profit margin?

What factors drove the changes in Weave Communications's revenue and profit?

What is the revenue and EPS growth rate for Weave Communications year over year?

What does Weave Communications do and what are its main business segments?

Did Weave Communications beat or miss consensus estimates last quarter?

- **Revenue Growth**: Q4 2025 revenue up 17% YoY to $63.4M, with full-year free cash flow +24% to $12.9M.
- **AI Expansion**: AI Receptionist booked 1,200+ appointments/month, with 2026 roadmap including payments automation and PMS integrations.
- **Strategic Partnership**: CareCredit integration to streamline patient financing, enhancing payment volumes and treatment acceptance.
- **2026 Outlook**: Revenue $273-276M, operating income $8-12M, driven by AI and payments growth.
- **Market Leadership**: 93% net retention, 102% multi-location NRR, and <2% AI Receptionist penetration in installed base.

**【CEO Summary Section】**
- **Q4 2025 Results**: Revenue grew 17% YoY to $63.4M, gross margin expanded to 73.3%, and operating income reached $2.3M, a 30bp sequential improvement. Full-year revenue was $239M (+17%), with free cash flow up 24% to $12.9M.
- **AI Strategy**: Launched omnichannel AI Receptionist in Q4, booking 1,200+ appointments/month for a key customer. 2026 roadmap includes payments automation (e.g., co-pay collections) and integration with practice management systems.
- **Partnerships**: Announced CareCredit partnership to streamline patient financing, enhancing payment capabilities and treatment acceptance rates.
- **Market Expansion**: Specialty medical became second-largest vertical, adding 4,628 locations YoY. Mid-market sales and AI Receptionist adoption drove upsell opportunities.

**【CFO Financial Commentary】**
- **Q4 Financials**: GAAP net income $4.1M, non-GAAP EPS $0.05. Gross margin +70bp YoY, operating expenses 70% of revenue (down 200bp in G&A). Free cash flow $4.4M, ending Q4 with $81.7M cash.
- **2026 Guidance**: Revenue $273-276M (+16-17%), operating income $8-12M. AI Receptionist and payments growth to drive margin expansion. Q1 2026 revenue $64.2-64.8M, operating income $1-2M.
- **Retention Metrics**: Gross retention 89%, net retention 93%. Multi-location NRR 102%, single-location 93%. Upsell penetration for AI Receptionist <2%, with strong pipeline.

**【Q&A Highlights】**
- **CareCredit Integration**: Will capture patient financing volumes directly, enhancing payment attach rates and revenue per location.
- **2026 Growth Drivers**: Specialty medical (1% market share) and mid-market sales to lead, with AI Receptionist adoption accelerating in Q2+.
- **Pricing Strategy**: Omnichannel AI Receptionist may be priced as a premium module, leveraging labor cost savings to justify premium pricing.
- **Competitive Edge**: Scale, HIPAA/PCI compliance, and domain expertise in SMB healthcare workflows differentiate Weave from horizontal AI providers.

Weave Communications, Inc. (WEAV) Q4 2025 Earnings Call Transcript

- **Revenue Acceleration**: Q3 2025 revenue of $61.3M (+17.1% YoY) driven by specialty medical and payments, with 15th straight quarter of guidance beat.
- **AI-Driven Efficiency**: AI receptionist booked $320K in new appointments in one quarter, while call intelligence flagged $80K in missed revenue.
- **Profitability Leap**: Operating income of $1.7M (2.7% margin) vs. prior guidance, with full-year non-GAAP operating income raised to $3.3-4.3M.
- **Cash Flow Strength**: $5M free cash flow in Q3, year-to-date total $8.5M (+$4.3M YoY), underpinning growth investments.
- **Growth Catalysts**: Payments revenue growing >2x total, AI integration with TrueLark, and <1% penetration in $10B+ specialty medical market.

**【CEO Summary Section】**
- **Revenue Growth**: Q3 2025 revenue reached $61.3 million, up 17.1% YoY, driven by specialty medical and payments. This marks the 15th consecutive quarter of exceeding revenue guidance.
- **Gross Margin Expansion**: Gross margin hit a record 73%, up 50 basis points YoY, due to cloud cost optimization and hardware amortization.
- **AI Advancements**: Introduced AI receptionist with voice capabilities, booking $320K+ in new appointments in one quarter. Call intelligence flagged $80K in missed revenue opportunities.
- **Market Expansion**: Specialty medical revenue grew more than any prior quarter, with mid-market pipeline diversifying into new healthcare segments.
- **Customer Retention**: Gross revenue retention remained steady at 90%, with net retention at 94%, reflecting strong customer loyalty.

**【CFO Financial Commentary】**
- **Profitability**: Operating income of $1.7 million (2.7% margin) exceeded guidance by $700K. Full-year guidance raised to $238-239M revenue and $3.3-4.3M non-GAAP operating income.
- **Cash Flow**: Generated $5M free cash flow in Q3, with year-to-date total of $8.5M, up $4.3M YoY.
- **Expense Management**: G&A expenses declined to 16% of revenue, providing operating leverage. R&D and sales expenses tracked growth investments.

**【Q&A Highlights】**
- **Payments Growth**: Payments revenue grew >2x total revenue, driven by surcharging, bulk collections, and EMR integrations. AI receptionist will soon handle payments workflows.
- **Specialty Medical Strategy**: Penetration <1% in a $10B+ market. Success with 600+ location group (50+ locations onboarding) highlights EMR partnership potential.
- **AI Integration**: TrueLark AI receptionist now sold to mid-market and single-location customers. Voice capabilities launching Q4 to handle 24/7 patient interactions.
- **Profitability Outlook**: 2026 investments in go-to-market and engineering will balance growth with incremental profitability, targeting sustainable margin expansion.

Weave Communications, Inc. (WEAV) Q3 2025 Earnings Call Transcript

- **Revenue Growth**: $58.5M (+15.6% YoY) with 72.3% gross margin, $4.5M free cash flow.
- **TrueLark Integration**: 24/7 scheduling automation added $35M, Q4 single-location launch planned.
- **Specialty Medical Expansion**: 1% share of $10B+ market, led by medical aesthetics and physical therapy.
- **AI Adoption**: 80% of fast-growing practices credit tech for growth, call intelligence adoption improving collections.
- **2025 Guidance**: $236.8M-$239.8M revenue, positive free cash flow expected.

**【CEO Summary Section】**
- Q2 revenue reached $58.5 million, up 15.6% YoY, driven by payments growth and TrueLark integration. Gross margin improved to 72.3%, with free cash flow of $4.5 million.
- Specialty medical vertical grew to second-largest segment, with 1% market share in a $10B+ addressable market. Medical aesthetics, physical therapy, and primary care led growth.
- TrueLark acquisition ($35M total consideration) added 24/7 scheduling automation, with 15,000+ monthly conversations for a multi-location customer. Integration with Weave inbox expected Q4.
- Promoted Abhi Sharma to CTO, accelerating AI-powered workflow innovation. Q2 saw record sales and 90% gross revenue retention.

**【CFO Financial Commentary】**
- Q2 non-GAAP EPS: $0.09 (vs. $0.07 prior year). Operating income improved $1M YoY to $70,000. Full-year 2025 revenue guidance: $236.8M-$239.8M (15.5%-17.5% growth).
- Sales & marketing expenses: $23.2M (40% of rev), up 25% YoY for mid-market expansion. R&D: $8.9M (15% of rev) for TrueLark integration.
- Cash balance: $77.8M post TrueLark acquisition. 2025 free cash flow expected to turn positive, up from $0.7M in 2024.

**【Q&A Highlights】**
- **Specialty Medical Growth**: 96% of practices report patient base growth, driving demand for Weave's recall reminders (e.g., $70K in added appointments for a single optometry office).
- **TrueLark Integration Progress**: Joint go-to-market teams closed multi-location deals, with single-location onboarding launching Q4. Customer feedback highlights 24/7 scheduling automation benefits.
- **AI Adoption**: 80% of fast-growing practices cite technology as a growth driver. Call intelligence adoption improving collections (e.g., $100K in 12 months for a dental practice).
- **Macroeconomic Resilience**: No consumer demand weakness observed; record Q2 sales and 96% NRR reflect strong SMB healthcare demand.
- **2026 Outlook**: TrueLark expected to be accretive, with mid-market and medical verticals driving 2025-2026 growth. Price increases under evaluation for 2026 cohorts.

Weave Communications, Inc. (WEAV) Q2 2025 Earnings Call Transcript

- **$35M TrueLark Acquisition**: Expands U.S. TAM to $10B, adds AI-powered front-desk automation for SMB healthcare practices.
- **Q1 2025 Results**: 18% YoY revenue growth to $55.8M, 72.1% gross margin, and $1M EBITDA.
- **Cross-Sell Opportunity**: TrueLark's 1,000+ customers represent <1% of Weave's 80,000+ locations, with potential to add $10M+ annual revenue.
- **Specialty Medical Surge**: Q1 medical locations added set a new record, driven by 3 new integrations.
- **Payment Growth**: Attach rate <10% but growing >2x revenue rate; AI-integrated payments workflows to accelerate adoption.

**【CEO Summary Section】**
- Announced the acquisition of TrueLark, an AI-powered front-desk automation platform, expanding the U.S. TAM to $10 billion.
- Q1 2025 revenue grew 18% YoY to $55.8 million, driven by specialty medical and payments growth.
- Highlighted TrueLark's value as a revenue-generating tool for SMB healthcare practices, with cross-sell opportunities across Weave's existing customer base.
- Introduced Abhi Sharma as Senior Vice President of Engineering to accelerate AI-driven innovation.
- Q1 gross margin improved to 72.1%, up 170bps YoY, reflecting operational efficiency.

**【CFO Financial Commentary】**
- Acquired TrueLark for $35 million ($25M cash, $10M equity), with performance-based equity tied to 2025-26 revenue milestones.
- Q1 non-GAAP operating income was $39,000, up $1.4M YoY, with adjusted EBITDA of $1M.
- 2025 full-year revenue guidance raised to $236.8-$239.8 million, including $2.5M from TrueLark.
- Q2 2025 revenue expected to grow 18-19% YoY, despite tough comparisons due to 2024 pricing adjustments.
- Operating expenses remain disciplined, with R&D and go-to-market investments to accelerate TrueLark integration.

**【Q&A Key Highlights】**
- **TrueLark Pricing & Monetization**: Sold on subscription basis with multi-year contracts; customers see 100% ROI within 6 months. Cross-sell to Weave's 80,000+ locations could add $10M+ annual revenue.
- **Specialty Medical Growth**: Q1 medical locations added set a new record, driven by integrations with Prompt, Practice Fusion, and Veradigm.
- **Payment Solutions**: Attach rate <10% but growing >2x revenue growth rate; integrating TrueLark's AI with payments workflows to accelerate adoption.
- **Market Resilience**: Dental and optometry verticals >10% penetrated, while specialty medical <1% penetrated. elective procedures (e.g., plastic surgery) show macro resilience due to inelastic demand.
- **Mid-Market Expansion**: New 30-location DSO win demonstrates ability to scale into multi-location groups through partner referrals.


Weave Communications (WEAV)-5 May 25-2025 Q1 Earnings call transcript

- **Record Growth**: Q4 2024 revenue up 19% YoY to $54.2M, with full-year revenue hitting $204.3M (+20% YoY).
- **Profitability Milestone**: First full-year operating profit in company history, with Q4 operating income of $1.8M.
- **Strategic Investments**: 
  - $10.4M free cash flow (+59% YoY) fuels expansion into medical verticals, AI, and mid-market.
  - New payments partnerships and AI-driven workflows expected to accelerate 2025 growth.
- **Key Metrics**: 
  - Gross margin 72.6% (up 290bps YoY)
  - NRR 98% (vs. 95% YoY)
  - 34%+ new medical locations added in Q4
- **2025 Outlook**: Target $232-237M revenue, with operating income of $2-6M, driven by disciplined investment in high-impact growth vectors.

**【CEO Key Highlights】**
- **Revenue Growth**: Q4 2024 revenue of $54.2M (+19% YoY), exceeding guidance midpoint by $1.1M. Full-year revenue reached $204.3M (+20% YoY).
- **Gross Margin Expansion**: Q4 gross margin improved to 72.6% (up 290bps YoY), 12th consecutive quarter of sequential improvement.
- **New Vectors of Growth**: 
  - **Specialty Medical Verticals**: Revenue grew twice the rate of overall company, with 34%+ new medical locations added in Q4.
  - **Partnerships**: Expanded integrations with eClinicalWorks, Athenahealth, and Prompt, reaching 100,000+ new locations.
  - **Mid-Market Expansion**: Secured Affordable Care as platform of record, with dedicated sales team expansion.
  - **AI Innovations**: Launched Call Intelligence, achieving 88% customer satisfaction rate for call analysis.
- **2025 Outlook**: Target $232-237M revenue, with operating income of $2-6M. Investments in payments, AI, and partnerships expected to drive long-term growth.

**【CFO Financial Breakdown】**
- **Profitability**: Q4 non-GAAP operating income of $1.8M (vs. -$3.5M YoY), full-year operating margin turned positive at 0.4%.
- **Cash Flow**: Q4 free cash flow of $6.1M (+109% YoY), full-year free cash flow of $10.4M (+59% YoY).
- **Expense Management**: 
  - Sales & Marketing: 37% of revenue (down from 38% YoY)
  - R&D: 15% of revenue (down from 16% YoY)
  - G&A: 17% of revenue (down from 19% YoY)
- **Balance Sheet**: $99.1M cash & short-term investments as of Q4 end.

**【Q&A Key Takeaways】**
1. **2025 Growth Strategy**: 
   - **Payments**: New Head of Payments, doubled engineering team, integrating ACI payments workflows.
   - **AI**: Call Intelligence monetized via premium bundles, with 74% of practices seeing faster collections.
   - **Partnerships**: Dedicated partner sales team to accelerate co-selling with Patterson Dental, Prompt.
2. **Challenges**: 
   - Q2 2025 will face tough comp from Q2 2024 pricing adjustments.
   - Section 404(b) compliance costs expected to rise.
3. **NRR Trends**: 
   - Q4 NRR 98% (vs. 95% YoY), driven by payments adoption and price adjustments.
   - GRR 91% (stable vs. prior years), among top SMB SaaS performers.


Actual	-0.72	-0.26	-0.16	-0.16	-0.1	-0.06	-0.05	-0.05	-0.01	-0.01	-0.01	-0.0037	0.03	0.03	0.01	0.02	0.02	0.03
Forecast	-0.7132	-0.2552	-0.1831	-0.1642	-0.1433	-0.1077	-0.0786	-0.0693	-0.0595	-0.0302	-0.0232	-0.0226	-0.0049	0.024	0.0093	0.0014	0.008	0.035
Surprise	-0.95%	-1.88%	+12.62%	+2.56%	+30.22%	+44.29%	+36.39%	+27.85%	+83.19%	+66.89%	+56.90%	+83.63%	+712.24%	+25.00%	+7.53%	+1328.57%	+150.00%	-14.29%

WEAV

WEAV fundamentals

WEAV Q4 2025 Earnings

Earnings Call

You can ask Aime

WEAV

WEAV fundamentals

WEAV Q4 2025 Earnings

Earnings Call

WEAV Earnings Call Summary for Q4/20254:30 PM on Feb 19, 2026

WEAV Earnings Call Summary for Q3/20254:30 PM on Oct 30, 2025

WEAV Earnings Call Summary for Q2/20254:30 PM on Jul 31, 2025

WEAV Earnings Call Summary for Q1/20254:30 PM on May 5, 2025

WEAV Earnings Call Summary for Q4/20244:30 PM on Feb 20, 2025

You can ask Aime